Cargando…

Novel carboxylate-based glycolipids: TLR4 antagonism, MD-2 binding and self-assembly properties

New monosaccharide-based lipid A analogues were rationally designed through MD-2 docking studies. A panel of compounds with two carboxylate groups as phosphates bioisosteres, was synthesized with the same glucosamine-bis-succinyl core linked to different unsaturated and saturated fatty acid chains....

Descripción completa

Detalles Bibliográficos
Autores principales:	Cochet, Florent, Facchini, Fabio A., Zaffaroni, Lenny, Billod, Jean-Marc, Coelho, Helena, Holgado, Aurora, Braun, Harald, Beyaert, Rudi, Jerala, Roman, Jimenez-Barbero, Jesus, Martin-Santamaria, Sonsoles, Peri, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351529/ https://www.ncbi.nlm.nih.gov/pubmed/30696900 http://dx.doi.org/10.1038/s41598-018-37421-w

Ejemplares similares

Exploring Species-Specificity in TLR4/MD-2 Inhibition with Amphiphilic Lipid A Mimicking Glycolipids
por: Borio, Alessio, et al.
Publicado: (2023)

Synthetic glycolipid-based TLR4 antagonists negatively regulate TRIF-dependent TLR4 signalling in human macrophages
por: Palmer, Charys, et al.
Publicado: (2021)

Induction of TLR4/TLR2 Interaction and Heterodimer Formation by Low Endotoxic Atypical LPS
por: Francisco, Sara, et al.
Publicado: (2022)

Anti-endotoxic activity and structural basis for human MD-2·TLR4 antagonism of tetraacylated lipid A mimetics based on βGlcN(1↔1)αGlcN scaffold
por: Garate, Jose Antonio, et al.
Publicado: (2015)

The Role of Carbohydrates in the Lipopolysaccharide (LPS)/Toll-Like Receptor 4 (TLR4) Signalling
por: Cochet, Florent, et al.
Publicado: (2017)

Synthetic Glycolipids as Molecular Vaccine Adjuvants: Mechanism of Action in Human Cells and In Vivo Activity
por: Facchini, Fabio A., et al.
Publicado: (2021)

MD-2 Determinants of Nickel and Cobalt-Mediated Activation of Human TLR4
por: Oblak, Alja, et al.
Publicado: (2015)

Bradyrhizobium Lipid A: Immunological Properties and Molecular Basis of Its Binding to the Myeloid Differentiation Protein-2/Toll-Like Receptor 4 Complex
por: Lembo-Fazio, Luigi, et al.
Publicado: (2018)

Species-Specific Activation of TLR4 by Hypoacylated Endotoxins Governed by Residues 82 and 122 of MD-2
por: Oblak, Alja, et al.
Publicado: (2014)

Co‐administration of Antimicrobial Peptides Enhances Toll‐like Receptor 4 Antagonist Activity of a Synthetic Glycolipid
por: Facchini, Fabio A., et al.
Publicado: (2018)

Computational Approaches to Toll-Like Receptor 4 Modulation
por: Billod, Jean-Marc, et al.
Publicado: (2016)

The synthetic glycolipid-based TLR4 antagonist FP7 negatively regulates in vitro and in vivo haematopoietic and non-haematopoietic vascular TLR4 signalling
por: Palmer, Charys, et al.
Publicado: (2018)

Pellino Proteins: Novel Players in TLR and IL-1R Signalling
por: Schauvliege, Reinout, et al.
Publicado: (2007)

Insights into the key determinants of membrane protein topology enable the identification of new monotopic folds
por: Entova, Sonya, et al.
Publicado: (2018)

Conformationally Constrained Lipid A Mimetics for Exploration of Structural Basis of TLR4/MD-2 Activation by Lipopolysaccharide
por: Artner, Daniel, et al.
Publicado: (2013)

Mycobacterial Phenolic Glycolipids Selectively Disable TRIF-Dependent TLR4 Signaling in Macrophages
por: Oldenburg, Reid, et al.
Publicado: (2018)

Vaccine adjuvant activity of a TLR4-activating synthetic glycolipid by promoting autophagy
por: Chou, Yi-Ju, et al.
Publicado: (2020)

Single-Chain Soluble Receptor Fusion Proteins as Versatile Cytokine Inhibitors
por: Holgado, Aurora, et al.
Publicado: (2020)

Full‐Atom Model of the Agonist LPS‐Bound Toll‐like Receptor 4 Dimer in a Membrane Environment
por: Matamoros‐Recio, Alejandra, et al.
Publicado: (2021)

Synthetic glycan-based TLR4 agonists targeting caspase-4/11 for the development of adjuvants and immunotherapeutics
por: Adanitsch, Florian, et al.
Publicado: (2018)

The Liganding of Glycolipid Transfer Protein Is Controlled by Glycolipid Acyl Structure
por: Malinina, Lucy, et al.
Publicado: (2006)

New Glucosamine-Based TLR4 Agonists: Design, Synthesis, Mechanism of Action, and In Vivo Activity as Vaccine Adjuvants
por: Romerio, Alessio, et al.
Publicado: (2023)

Structural analysis reveals TLR7 dynamics underlying antagonism
por: Tojo, Shingo, et al.
Publicado: (2020)

Development of αGlcN(1↔1)αMan-Based Lipid A Mimetics as a Novel Class of Potent Toll-like Receptor 4 Agonists
por: Adanitsch, Florian, et al.
Publicado: (2014)

Oligosaccharide Presentation Modulates the Molecular Recognition of Glycolipids by Galectins on Membrane Surfaces
por: Lete, Marta G., et al.
Publicado: (2022)

Glycolipids anchor laminin
por: Tuma, Rabiya S.
Publicado: (2005)

Suppression of TLR Signaling by Targeting TIR domain-Containing Proteins
por: Fekonja, Ota, et al.
Publicado: (2012)

Contributions of Glycolipid Biosurfactants and Glycolipid-Modified Materials to Antimicrobial Strategy: A Review
por: Shu, Qin, et al.
Publicado: (2021)

Structure and antagonism of the receptor complex mediated by human TSLP in allergy and asthma
por: Verstraete, Kenneth, et al.
Publicado: (2017)

Tailored Modulation of Cellular Pro-inflammatory Responses With Disaccharide Lipid A Mimetics
por: Heine, Holger, et al.
Publicado: (2021)

Inefficient TLR4/MD-2 Heterotetramerization by Monophosphoryl Lipid A
por: Casella, Carolyn R., et al.
Publicado: (2013)

TLR4/MD-2 is a receptor for extracellular nucleophosmin 1
por: Nakatomi, Kota, et al.
Publicado: (2021)

Decreased glycolipid antigen expression in lymphoma cell variants escaping from anti-glycolipid serotherapy
Publicado: (1983)

Partially Glycosylated Dendrimers Block MD-2 and Prevent TLR4-MD-2-LPS Complex Mediated Cytokine Responses
por: Barata, Teresa S., et al.
Publicado: (2011)

Recognition of lipid A variants by the TLR4-MD-2 receptor complex
por: Maeshima, Nina, et al.
Publicado: (2013)

MD-2 is required for disulfide HMGB1–dependent TLR4 signaling
por: Yang, Huan, et al.
Publicado: (2015)

Identification of a Heme Activation Site on the MD-2/TLR4 Complex
por: Belcher, John D., et al.
Publicado: (2020)

Astilbin prevents osteoarthritis development through the TLR4/MD‐2 pathway
por: Sun, Shuaibo, et al.
Publicado: (2020)

Inflammation and NF-κB Signaling in Prostate Cancer: Mechanisms and Clinical Implications
por: Staal, Jens, et al.
Publicado: (2018)

The Effects of Oral and Enteric Campylobacter concisus Strains on Expression of TLR4, MD-2, TLR2, TLR5 and COX-2 in HT-29 Cells
por: Ismail, Yazan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_gtj3nl05pjprmttpfrcmpglfna